Celon Pharma S.A. was presented with another award given to leaders of the capital market – Stock Exchange Summary of the Year 2016. The company was awarded the Bull statuette in the category: Award for the highest value of the initial public offering in 2016. The award was accepted on behalf of the company by Bogdan Manowski, Member of the Management Board at Celon Pharma S.A.,Director for Business Development.
We were among a small group of companies who decided to make our initial public offering on our shares in 2016. Now, everyday assures us that we took the correct path – said Bogdan Manowski, Director for Business Development, Member of the Board at Celon Pharma S.A.
Maciej Wieczorek, President of the Board at Celon Pharma S.A.: On the one hand, the success of this offer shows that we are an attractive company with a clearly defined business strategy and vision for the future which enjoys the trust of investors. On the other hand, it also confirms that the capital market and its instruments play a crucial role in creating innovations in Poland. We would not be able to win in this category without the trust put in us by our investors who have made this offer so successful by buying Celon Pharma's shares. Therefore we treat this award as an obligation to keep your trust and stay in the leader circle of the Polish capital market.
The Stock Exchange Summary of the Year is a gala organised annually by the Warsaw Stock Exchange. During this event, the Warsaw Stock Exchange hands out awards to Stock Exchange Members and Authorised Advisers who achieved the best results in the previous calendar year and contributed to the development of the Polish capital market.